Toshio Yoshizawa

A phase 1 clinical trial of the selective BTK inhibitor ONO/GS-4059 in relapsed and refractory mature B-cell malignancies

Harriet S. Walter, Simon A. Rule, Martin J.S. Dyer et al. · Blood · 2015 · 262 citations · Full text

Calpain Dissociates into Subunits in the Presence Ions

Toshio Yoshizawa, Hiroyuki Sorimachi, Sadatake Tomioka et al. · Biochemical and Biophysical Research Communications · 1995 · 91 citations

Protein Chemistry, Molecular Physiology, Biochemistry +9

A catalytic subunit of calpain possesses full proteolytic activity

Toshio Yoshizawa, Hiroyuki Sorimachi, Shigeo Tomioka et al. · FEBS Letters · 1995 · 85 citations · Full text

Full Protease Activity, Biochemistry, Protein Assembly +11

Autoantibodies to calpastatin (an endogenous inhibitor for calcium-dependent neutral protease, calpain) in systemic rheumatic diseases.

Tsuneyo Mimori, Keisuke Suganuma, YOH TANAMI et al. · Proceedings of the National Academy of Sciences · 1995 · 68 citations · Full text

Systemic Rheumatic Diseases, Human Calpastatin, Immunology +21

Distinct kinetics of subunit autolysis in mammalian m‐calpain activation

Takaomi C. Saido, Shunsuke Nagao, Mikiro Shiramine et al. · FEBS Letters · 1994 · 66 citations